Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    March 2017

  1. Case 39-2016: A Man with a History of Prostate Cancer and Recent Rectal Bleeding.
    N Engl J Med. 2017;376:897-8.
    PubMed     Text format    


  2. HONG TS, Allen JN, Shellito PC
    Case 39-2016: A Man with a History of Prostate Cancer and Recent Rectal Bleeding.
    N Engl J Med. 2017;376:898.
    PubMed     Text format    


    February 2017
  3. THOMPSON IM JR
    Improved Therapy for PSA Recurrence after Prostatectomy.
    N Engl J Med. 2017;376:484-485.
    PubMed     Text format    


  4. SHIPLEY WU, Seiferheld W, Lukka HR, Major PP, et al
    Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
    N Engl J Med. 2017;376:417-428.
    PubMed     Text format     Abstract available


    January 2017
  5. D'AMICO AV
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:180-1.
    PubMed     Text format    


  6. KELLEHER MH
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:179-80.
    PubMed     Text format    


  7. NOCERA L, Karabon P, Abdollah F
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:178-9.
    PubMed     Text format    


  8. KLOTZ L, Kibel A, et al.
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:178.
    PubMed     Text format    


  9. STAINSBY GD
    10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:179.
    PubMed     Text format    



  10. 10-Year Outcomes in Localized Prostate Cancer.
    N Engl J Med. 2017;376:180.
    PubMed     Text format    


    December 2016
  11. HONG TS, Gray PJ, Allen JN, Shellito PC, et al
    Case 39-2016. A 74-Year-Old Man with Rectal Bleeding and a History of Prostate Cancer.
    N Engl J Med. 2016;375:2481-2488.
    PubMed     Text format    


    November 2016
  12. FOULKES WD
    DNA-Repair Gene Mutations in Metastatic Prostate Cancer.
    N Engl J Med. 2016;375:1803.
    PubMed     Text format    


  13. NA R, Xu J, Isaacs WB
    DNA-Repair Gene Mutations in Metastatic Prostate Cancer.
    N Engl J Med. 2016;375:1802-1803.
    PubMed     Text format    



  14. DNA-Repair Gene Mutations in Metastatic Prostate Cancer.
    N Engl J Med. 2016;375:1802-1805.
    PubMed     Text format    


  15. MYGATT JG, Osborn DJ
    DNA-Repair Gene Mutations in Metastatic Prostate Cancer.
    N Engl J Med. 2016;375:1803-4.
    PubMed     Text format    


    October 2016
  16. PINSKY P, Prorok P
    More on Reevaluating PSA Testing Rates in the PLCO Trial.
    N Engl J Med. 2016;375:1500-1501.
    PubMed     Text format    



  17. More on Reevaluating PSA Testing Rates in the PLCO Trial.
    N Engl J Med. 2016;375:1500-1501.
    PubMed     Text format    


    September 2016
  18. D'AMICO AV
    Treatment or Monitoring for Early Prostate Cancer.
    N Engl J Med. 2016.
    PubMed     Text format    


  19. DONOVAN JL, Hamdy FC, Lane JA, Mason M, et al
    Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  20. HAMDY FC, Donovan JL, Lane JA, Mason M, et al
    10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    July 2016
  21. PRITCHARD CC, Mateo J, Walsh MF, De Sarkar N, et al
    Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  22. SHOAG JE, Mittal S, Hu JC
    Reevaluating PSA Testing Rates in the PLCO Trial.
    N Engl J Med. 2016;374:1795-6.
    PubMed     Text format    


    February 2016
  23. FOUAD TM
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:595.
    PubMed     Text format    


  24. EBY PR
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:595.
    PubMed     Text format    


  25. GAYLIS FD, Choi J, Kader AK
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:594-5.
    PubMed     Text format    


  26. WELCH HG, Gorski DH, Albertsen PC
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:596.
    PubMed     Text format    


    January 2016
  27. CICCARESE C, Santoni M, Massari F
    Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer.
    N Engl J Med. 2016;374:286.
    PubMed     Text format    


  28. GARCIA JA, Sweeney C
    Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer.
    N Engl J Med. 2016;374:287.
    PubMed     Text format    


    October 2015
  29. MATEO J, Carreira S, Sandhu S, Miranda S, et al
    DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
    N Engl J Med. 2015;373:1697-708.
    PubMed     Text format     Abstract available


  30. WELCH HG, Gorski DH, Albertsen PC
    Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.
    N Engl J Med. 2015;373:1685-7.
    PubMed     Text format    


    August 2015
  31. SWEENEY CJ, Chen YH, Carducci M, Liu G, et al
    Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    June 2015
  32. CARRIER M, Lazo-Langner A, Shivakumar S, Tagalakis V, et al
    Screening for Occult Cancer in Unprovoked Venous Thromboembolism.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: